Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Methods and biomarkers for the diagnosis and prognosis of cancer and other diseases: towards personalized medicine.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy - 1 Jan 2000

Anderson Judy E, Hansen Lise Lotte, Mooren Frank C, Post Markus, Hug Hubert, Zuse Anne, Los Marek

Abstract excerpt

The rapid development of new diagnostic procedures, the mapping of the human genome, progress in mapping genetic polymorphisms, and recent advances in nucleic acid- and protein chip technologies are driving the development of personalized therapies. This breakthrough in medicine is expected to be achieved largely due to the implementation of "lab-on-the-chip" technology capable of performing hundreds, even...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to Cell Death

Share to Immunohistochemistry

Share to Magnetic Resonance Spectroscopy

Share to Muscular Dystrophies

Share to Oligonucleotide Array Sequence Analysis

Source

Identifiers

PMID: 17011811
DOI: 10.1016/j.drup.2006.08.001

Genes

DMD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Methods and biomarkers for the diagnosis and prognosis of cancer and other diseases: towards personalized medicine.PMID 17011811Read ↗

Duchenne Muscular Dystrophy: recent advances in protein biomarkers and the clinical applicationSemantic proximity Read ↗

Personalized clinical laboratory diagnostics.Semantic proximity Read ↗

Circulating Biomarkers for Duchenne Muscular DystrophySemantic proximity Read ↗

Orthogonal proteomics methods warrants development of Duchenne Muscular Dystrophy biomarkersSemantic proximity Read ↗

Biomarkers in Disease Diagnosis and Monitoring: Insights into Clinical Applications and Mass Spectrometry-based DetectionSemantic proximity Read ↗

204th ENMC International Workshop on Biomarkers in Duchenne Muscular Dystrophy 24–26 January 2014, Naarden, The NetherlandsSemantic proximity Read ↗

Large-scale serum protein biomarker discovery in Duchenne muscular dystrophySemantic proximity Read ↗

Advancing Biomarker Discovery and Therapeutic Targets in Duchenne Muscular Dystrophy: A Comprehensive ReviewSemantic proximity Read ↗

Diagnostic Molecular Pathology: Current Techniques and Clinical Applications, Part ISemantic proximity Read ↗

Novel Autoimmune Hepatitis-Specific Autoantigens Identified Using Protein Microarray TechnologySemantic proximity Read ↗

Contrasting Becker and Duchenne muscular dystrophy serum biomarker candidates by using data independent acquisition LC-MS/MSSemantic proximity Read ↗

Emerging proteomic biomarkers of X-linked muscular dystrophySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.